| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2021 12-31 |
|---|---|---|---|
| Report Filing | 2025-11-14 | 2025-03-31 | 2022-02-24 |
| Revenue | 82.05 | 56.59 | 0 |
| Cost of Revenue | 22.92 | 16.69 | 1.01 |
| Gross Profit | 59.13 | 39.9 | -1.01 |
| Operating Expenses | 375 | 123.3 | 0 |
| Research & Development | 22.18 | 9.64 | 0 |
| Selling, General and Administrative | 355.7 | 119 | 0 |
| Other Operating Expenses | -2.89 | -5.36 | 0 |
| Operating Income | -315.9 | -83.4 | -1.01 |
| Net Non-Operating Interest | -9.71 | -1.96 | 0.029 |
| Interest Income | 0.194 | 0 | 0.031 |
| Interest Expense | 9.91 | 1.96 | 0.002 |
| Equity & Other Income/(Expense) | -75.75 | 12.55 | 1.76 |
| Income Before Tax | -401.4 | -72.81 | 0.783 |
| Income Tax Expense | 2.89 | -0.001 | 0 |
| Income Attributable to Non-Controlling Interest | -3.46 | 0 | 0 |
| Net Income | -400.8 | -72.81 | 0.783 |
| Depreciation and Amortization | 0.802 | 0 | 0.031 |
| EBITDA | -315.1 | -83.4 | -0.975 |
| Earnings Per Share (EPS) | -32.41 | -0.56 | 0.05 |
| Diluted Earnings Per Share | -32.46 | -0.61 | 0.05 |
| Weighted Average Shares Outstanding | 11.6 | 131.1 | 16,821 |
| Diluted Weighted Average Shares Outstanding | 11.6 | 131.1 | 16,834 |
